By A patient with relapsed T cell leukaemia has been given base-edited T-cells in a world-first use of a base-edited cell therapy, in a ‘bench-to-bedside’ collaboration between UCL and Great Ormond Street Hospital for Children (GOSH).
World-first use of base-edited CAR T cells to treat resistant leukemia
Corporate businessmen working on tablet at office
Comments